新型免疫调节药来那度胺的专利技术分析

Patent technology analysis for lenalidomide,a new immunomodulatory drug

来那度胺是由Celgene公司研发并上市的一种免疫调节药,是医药领域的超级重磅炸弹式药物。本文对来那度胺相关专利申请进行了分析,并深入解读了原研企业的专利申请与专利布局策略,对比分析了竞争企业的专利挑战策略,为国内医药研发机构及有关企业对来那度胺的研究开发提供参考。

Lenalidomide,developed and marketed by Celgene Corporation,was a super heavy bomb in the field of medicine for its remarkable sales. In this article,lenalidomide-related patent applications were analyzed to study the application strategy of the originator as well as the competitive enterprises. The competitors＇ patent challenge strategies were also analyzed to provide some helpful references on lenalidomide-related research and development for domestic pharmaceutical research and enterprises.